Patents by Inventor Frank Peter Hollinger

Frank Peter Hollinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds, their synthesis and their uses
    Patent number: 9556156
    Abstract: The present invention discloses novel chemical compounds obtained by causing a covalent attachment of a modifying agent of the structure provided for formula 1, to a functional group or a heteroatom of a heterocyclic ring system in chemical compound with improved chemical and biological properties. Wherein: Y is DRUG-CO; DRUG-OCO; DRUG-NRCO, and X is selected from.
    Type: Grant
    Filed: October 7, 2013
    Date of Patent: January 31, 2017
    Assignee: SPHAERA PHARMA PTE LTD.
    Inventors: Sundeep Dugar, Frank Peter Hollinger, Dinesh Mahajan, Rhushikesh Chandrabhan Deokar
  • Triazine compounds
    Patent number: 9481670
    Abstract: The present invention relates to novel triazine compounds of formula (1), methods of their preparation, pharmaceutical compositions containing these compounds and the use of these compounds to treat proliferative disorders such as tumors and cancers and also other conditions and disorders related to or associated with dysregulation of PI3 Kinases, PI3 Kinase pathway, mTOR and/or the mTOR pathway.
    Type: Grant
    Filed: January 25, 2012
    Date of Patent: November 1, 2016
    Assignee: Sphaera Pharma PTE. Ltd.
    Inventors: Sundeep Dugar, Dinesh Mahajan, Chandraban Rhushikesh Deokar, Frank Peter Hollinger, Kamal Kishore Kapoor
  • Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds
    Patent number: 9359376
    Abstract: The present invention relates to the synthesis and application of novel chiral/achiral substituted methyl formyl reagents to modify pharmaceutical agents and/or biologically active substances to modify the physicochemical, biological and/or pharmacokinetic properties of the resulting compounds from the unmodified original agent.
    Type: Grant
    Filed: April 9, 2012
    Date of Patent: June 7, 2016
    Assignee: SPHAERA PHARMA PTE. LTD
    Inventors: Sundeep Dugar, Dinesh Mahajan, Frank Peter Hollinger
  • NOVEL COMPOUNDS, THEIR SYNTHESIS AND THEIR USES
    Publication number: 20150252027
    Abstract: The present invention discloses novel chemical compounds obtained by causing a covalent attachment of a modifying agent of the structure provided for formula 1, to a functional group or a heteroatom of a heterocyclic ring system in chemical compound with improved chemical and biological properties. Wherein: Y is DRUG-CO; DRUG-OCO; DRUG-NRCO, and X is selected from.
    Type: Application
    Filed: October 7, 2013
    Publication date: September 10, 2015
    Applicant: Sphaera Pharma Pte Ltd.
    Inventors: Sundeep Dugar, Frank Peter Hollinger, Dinesh Mahajan, Rhushikesh Chandrabhan Deokar
  • SUBSTITUTED METHYLFORMYL REAGENTS AND METHOD OF USING SAME TO MODIFY PHYSICOCHEMICAL AND/OR PHARMACOKINETIC PROPERTIES OF COMPOUNDS
    Publication number: 20140121367
    Abstract: The present invention relates to the synthesis and application of novel chiral/achiral substituted methyl formyl reagents to modify pharmaceutical agents and/or biologically active substances to modify the physicochemical, biological and/or pharmacokinetic properties of the resulting compounds from the unmodified original agent.
    Type: Application
    Filed: April 9, 2012
    Publication date: May 1, 2014
    Inventors: Sundeep Dugar, Dinesh Mahajan, Frank Peter Hollinger